Skip to main content
Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · IEX Real-Time Price · USD
3.170
+0.020 (0.63%)
At close: Apr 24, 2024, 4:00 PM
3.100
-0.070 (-2.21%)
After-hours: Apr 24, 2024, 7:37 PM EDT

Virpax Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for VRPX.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for VRPX.

Recommendation Trends

Rating Jun '22
Strong Buy 0
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 0

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Naz Rahman
Maxim Group
 Maxim Group
Strong Buy
Initiates
$40
 Strong Buy Initiates $40 +1,161.83% Jun 9, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-7.45
from -12.97
EPS Next Year
-7.55
from -7.45
Year 2019202020212022202320242025202620272028
Revenue
--------57.72M99.33M
Revenue Growth
---------72.08%
EPS
-11.30-14.00-18.10-18.49-12.97-7.45-7.55-7.24--
EPS Growth
----------
No. Analysts -----33333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a n/a 59.4M 102.3M
Avg n/a n/a n/a 57.7M 99.3M
Low n/a n/a n/a 55.5M 95.4M

Revenue Growth

Revenue Growth 20242025202620272028
High - - - -
77.1%
Avg - - - -
72.1%
Low - - - -
65.3%

EPS Forecast

EPS 202420252026
High -7.67 -7.77 -7.46
Avg -7.45 -7.55 -7.24
Low -7.15 -7.25 -6.96

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.